Related Experiment Video
Updated: Aug 13, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting
Julie M Hall1, Donald P McDonnell
1Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.
Abstract:
Estrogens are key regulators of growth, differentiation, and the physiological functions of a wide range of target tissues, including the male and female reproductive tracts, breast, and skeletal, nervous, cardiovascular, digestive and immune systems. The majority of these biological activities of estrogens are mediated through two genetically distinct receptors, ERalpha and ERbeta, which function as hormone-inducible transcription factors. Over the past decade, it has become increasingly clear that the recruitment of coregulatory proteins to ERs is required for ER-mediated transcriptional and biological activities. These "coactivator" complexes enable the ERs to respond appropriately: 1) to hormones or pharmacological ligands, 2) interpret extra- and intra-cellular signals, 3) catalyze the process of chromatin condensation and 4) to communicate with the general transcription apparatus at target gene promoters. In addition to activating proteins, the existence of corepressors, proteins that function as negative regulators of ER activity in either physiological or pharmacological contexts, provides an additional level of complexity in ER action. This review also describes current efforts aimed at developing pharmaceutical agents that target ER-cofactor interactions as therapeutics for estrogen-associated pathologies.
Insights
Estrogen receptors (ERalpha and ERbeta) regulate many bodily functions by interacting with coactivator and corepressor proteins. Targeting these interactions offers new therapeutic strategies for estrogen-related diseases.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- Estrogens are critical hormones influencing numerous physiological processes via estrogen receptors (ERs).
- ERalpha and ERbeta act as ligand-inducible transcription factors, mediating diverse biological effects.
- Coregulatory proteins (coactivators and corepressors) are essential for ER-mediated gene transcription.
Purpose of the Study:
- To review the role of coregulatory proteins in estrogen receptor signaling.
- To discuss the mechanisms by which coactivators and corepressors modulate ER activity.
- To highlight therapeutic strategies targeting ER-cofactor interactions for estrogen-associated pathologies.
Main Methods:
- Literature review of studies on estrogen receptor function and coregulatory proteins.
- Analysis of molecular mechanisms underlying ER-cofactor complex formation and function.
- Examination of current pharmaceutical approaches targeting ER-cofactor interactions.
Main Results:
- Coregulatory proteins are indispensable for ERs to transduce hormonal signals and regulate gene expression.
- Coactivators facilitate hormone response, signal interpretation, chromatin modulation, and transcription initiation.
- Corepressors provide an additional layer of regulation, acting as negative regulators of ER activity.
Conclusions:
- Understanding ER-cofactor dynamics is crucial for comprehending estrogen's diverse physiological roles.
- Targeting ER-cofactor interactions presents a promising avenue for developing novel therapeutics for hormone-dependent diseases.
- Future research should focus on elucidating specific cofactor roles and developing selective modulators.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Co-activators and Co-repressors
Co-activators and Co-repressors
Signal Transduction: Overview
Typically, signal transduction involves three...
Regulation of Nuclear Protein Sorting
Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...

